Advanced search×

Infliximab Maintenance Therapy Is Associated With Decreases in Direct Resource Use in Patients With Luminal or Fistulizing Crohnʼs Disease

Carlos Taxonera, Luis Rodrigo, Francesc Casellas, Xavier Calvet, Federico Gómez-Camacho, Daniel Ginard, Manuel Castro, Luisa Castro, Marta Ponce, Pilar Martínez-Montiel, Elena Ricart, Javier P Gisbert, Antonio López-San Román, José M Morales, and Miguel Á Casado

J Clin Gastroenterol 43(10):950-956 (2009) PMID 19448569

To estimate the impact of infliximab (IFX) maintenance therapy on the use of hospital resources in patients with Crohn's disease (CD).

DOI: 10.1097/MCG.0b013e3181986917
Version: za2963e q8za0 q8zb4 q8zc9 q8zd1 q8zef q8zf8 q8zg2
Buy PDF

Similar articles you may find interesting…

  1. Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C) Study: background, rationale, and study protocol.
    Richard Haynes, Colin Baigent, and Peter Friend

    Transplantation Research 2(1):7 (2013) PMID 23641902

    BACKGROUND: Kidney transplantation is the best treatment for patients with end-stage renal failure, but uncertainty remains about the best immunosuppression strategy. Long-term graft survival has not improved substantially, and one possible explanation is calcineurin inhibitor (CNI)...
    Buy PDF
  2. Virologic response during up to 2 years of entecavir plus adefovir combination therapy in multiple drug-refractory chronic hepatitis B patie...
    Young-Suk Lim, Ji-Young Lee, and Dong Jin Suh

    Antimicrob Agents Chemother (2013) PMID 23650172

    One year trial with entecavir plus adefovir resulted in a higher rate of virological response (VR) compared with lamivudine plus adefovir in multiple drug-refractory chronic hepatitis B (CHB) patients. This extension study enrolled 89 of 90 patients who completed a 52-week randomized...
    Buy PDF
  3. Ovarian Cancer Incidence Trends in Relation to Changing Patterns of Menopausal Hormone Therapy Use in the United States.
    Hannah P Yang, William F Anderson, and Mark E Sherman

    J Clin Oncol (2013) PMID 23650423

    We tested whether ovarian cancer incidence rates changed after 2002. METHODSUsing the North American Association of Central Cancer Registries database (1995 to 2008; N = 171,142 incident ovarian cancers), we applied standard analytic approaches and age-period-cohort (APC) models to estimate ovarian...
    Buy PDF